Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.

Endocrine-related cancer - 1 Jan 2014

Kim Min-Hee, Bae Ja Seong, Lim Dong-Jun, Lee Hyoungnam, Jeon So Ra, Park Gyeong Sin, Jung Chan Kwon

Abstract excerpt

The BRAF V600E mutation is the most common genetic alteration in thyroid cancer. However, its clinicopathological significance and clonal mutation frequency remain unclear. To clarify the inconsistent results, we investigated the association between the allelic frequency of BRAF V600E and the clinicopathological features of classic papillary thyroid carcinoma (PTC). Tumour tissues from two independent sets of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 25266729
DOI: 10.1530/ERC-14-0147

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.PMID 25266729Read ↗

Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.Semantic proximity Read ↗

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.Semantic proximity Read ↗

Clinical implications of the extent of BRAFV600E alleles in patients with papillary thyroid carcinoma.Semantic proximity Read ↗

Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population.Semantic proximity Read ↗

Significance of allelic percentage of BRAF c.1799T > A (V600E) mutation in papillary thyroid carcinoma.Semantic proximity Read ↗

Association of BRAF V600E Allele Frequency With Clinicopathologic Outcomes in Papillary Thyroid CancerSemantic proximity Read ↗

The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer.Semantic proximity Read ↗

The ratio of BRAFV600E alleles can be used to assess the biological behavior of papillary thyroid carcinomaSemantic proximity Read ↗

Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression.Semantic proximity Read ↗

Can mutation abundance assess the biological behavior of BRAFV600E-positive papillary thyroid carcinoma?Semantic proximity Read ↗

Prevalence and Clinicopathological Significance of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Retrospective Cohort Study from Kerala, IndiaSemantic proximity Read ↗

Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.